Position in AXGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$128,241,286
+$6,504,120 QoQ
Shares Held
3,870,851
+4.1% QoQ
Ownership
7.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 97.70649916517065.ToString("F0")%
Shared 0.ToString("F0")%
None 2.2935008348293437.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026BlackRock, Inc. holds $66,751,105,265 across 112 Medical Devices names. AXGN ranks #32 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
145,687,458 | $14,957,731,302 | |
| 2 | MDT |
Medtronic plc
|
113,182,567 | $9,807,269,421 | |
| 3 | SYK |
Stryker Corp
|
27,602,049 | $9,069,757,269 | |
| 4 | BSX |
Boston Scientific Corp
|
131,822,037 | $8,271,832,814 | |
| 5 | EW |
Edwards Lifesciences Corp
|
52,590,933 | $4,211,481,905 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
35,984,327 | $2,561,364,385 | |
| 7 | DXCM |
Dexcom Inc
|
38,964,371 | $2,446,962,491 | |
| 8 | STE |
STERIS plc
|
9,026,621 | $1,996,056,695 |
All Filings in AXGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $128,241,286 | 3,870,851 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $121,737,166 | 3,719,437 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $64,387,373 | 3,609,158 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $37,978,141 | 3,500,290 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $65,690,814 | 3,550,855 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $56,044,454 | 3,400,756 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $47,845,869 | 3,412,687 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||